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Background/aim: The measurement of self-efficacy is an important step toward improving chronic disease management, enhancing
adherence to treatment, and assessing patients with chronic diseases. The purpose of this study was to assess the validity and reliability
of the Turkish version of the Self-Efficacy for Managing Chronic Disease 6-Item Scale.
Materials and methods: In this methodological study, the sample consisted of 211 patients receiving chronic disease care in 2 family
health centers in İstanbul, Turkey. Data were analyzed with descriptive statistics, exploratory and confirmatory factor analyses,
concurrent validity, Cronbach’s alpha, item-total correlation, and test-retest reliability.
Results: Most of the sample were women (72%), primary school graduates (41.7%), hypertensive (68.7%), and had comorbidities
(68.2%). The mean age of the sample was 60.5 ± 10.9. The scale mean was 5.66 ± 2.28. Cronbach’s alpha reliability was 0.90. Item-total
correlations were between 0.64–0.85 and test-retest reliability was high (R = 0.95, P < 0.001). A positive, significant correlation was
found in concurrent validity. According to the results of factor analysis, the scale had a 2-dimensional structure.
Conclusion: The Turkish version of the Self-Efficacy for Managing Chronic Disease 6-Item Scale is a valid and reliable instrument to
assess perceived the self-efficacy level of patient with chronic disease.
Key words: Chronic disease, self-efficacy, reliability, validity

1. Introduction
Chronic diseases constitute a large part of diseases that
cause mortality in Turkey as well as all over the world,
and the burden of chronic diseases will widely increase
[1–3]. People with chronic diseases should switch to
healthy lifestyle behavior and maintain it, and take
up new tasks every day [4]. Management of chronic
diseases includes more than treatment of the disease; it
also includes strengthening the patient through various
teaching methods to gain self-management skills [5,6].
Self-management is a part of daily life for people who
have lived for many years with chronic diseases, and
each day they make self-management decisions, or take
problem-solving actions throughout their lives [4,7]. Selfmanagement skills also consist of finding and utilizing
resources, collaboration between patient and health care
providers, and taking action with self-efficacy [4].
Self-efficacy is defined as a person’s beliefs about
their capabilities for carrying out an action plan, tackling
challenges, and making judgments in making a specific

action successful. It affects behavior choice and the
environment [8,9]. Self-efficacy is a central component, a
significant outcome variable, and an important indicator
for deciding health education programs, a major part
of behavior change processes, and a precondition for a
successful self-management of chronic diseases [7,10–12].
High self-efficacy is related to better health status, the
improvement of health behavior, motivation, problemsolving and complex thinking skills, healing, decisionmaking, psychological well-being, and fewer emergency
department visits [4,8,13–15].
The measurement of self-efficacy is an important
step toward improving chronic disease management,
enhancing adherence to the recommended treatment, and
assessing patients in terms of chronic diseases [11,16,17].
Determining the level of a patient’s perceived self-efficacy
provides assistance in deciding on suitable interventions for
increased self-care, planning patient education programs,
predicting the level of a patient’s intent, readiness, the
support needed for behavioral change and maintenance,
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and evaluating the impact of interventions [11,16,17].
There are various tools for measuring self-efficacy in the
literature. Many of these tools assess general or condition/
disease-specific self-efficacy [18], such as the Arthritis SelfEfficacy Scale [19], Diabetes Management Self-Efficacy
Scale [20,21], Medication Adherence Self-Efficacy Scale
[22], Generalized Perceived Self-Efficacy Scale [23,24],
Self-Efficacy Scale [25], General Self-Eﬃcacy Scale [26],
COPD Self-Efficacy Scale [27], and Medication Adherence
Self-Efficacy Scale-Short Form [28]. On the other hand,
these available instruments evaluate generic or just a
single disease or condition-specific self-efficacy level. The
Self-Efficacy for Managing Chronic Disease 6-Item Scale
is a brief and effective tool that directly measures the selfefficacy for chronic diseases. In this context, the purpose
of this study was to assess the validity and reliability of the
Turkish version of the Self-Efficacy for Managing Chronic
Disease 6-Item Scale. In this way, cross-cultural studies
or comparisons regarding self-efficacy in chronic disease
management may be possible.
2. Materials and methods
2.1. Study design, setting and sample
This methodological study was conducted as a preliminary
study of an experimental study aimed to evaluate
the results of the motivational interview-based selfmanagement support program for hypertensive patients
in 2 family health centers in İstanbul, Turkey. Accordingly,
the study was carried out in densely populated and
centrally located family health centers where individuals
of different socioeconomic levels receive health services.
Family health centers are 1 of the units in which preventive
and therapeutic health care services (such as maternalchild health, immunization, family planning services, and
diagnosing, treating, monitoring, and following up for
chronic diseases) are provided for the community. These
centers are places where people with chronic diseases are
diagnosed, treated and provided with home visits and
other primary health care services. Additionally, in such
places, rehabilitation and coordination with secondary
and tertiary health services are carried out, and individual
health records are kept and monitored [29].
The sample of this study includes 211 patients with
chronic diseases. For methodological research, the
sample size is recommended to be at least 5–10 times
more than the number of the items of the scale [30,31].
Purposeful sampling method was used in the study
and the sampling criteria were determined as follows:
being 18 years of age or older, having 1 or more chronic
disease for 6 months or longer, having no hearingvisual impairments or mental problems, and agreeing to

participate in the study. Individuals who were diagnosed
with Alzheimer’s, a psychiatric disease, had malignancy,
or refused to participate were excluded from the study.
The Turkish version of the Standardized Mini-Mental
State Examination was used to assess the cognitive status
of individuals who were older than 65 years. Patients who
scored above the threshold (23/24) set for the Turkish
community were included in the study [32]. Since the list
of individuals with chronic disease was not available at
the time of the study, the sample consisted of patients in
the waiting rooms of the centers. Within the scope of the
research, a similar number of individuals were included
in the study from each family health centers. Fifty-four
percent (n = 114) of the sample was selected from the first,
and 46% (n = 97) from the second family health center.
2.2. Instruments
The Interview Form, the Self-Efficacy for Managing
Chronic Disease 6-Item Scale, and the General Perceived
Self-Efficacy Scale were the data collection tools of this
study. The interview form consisted of questions including
the sociodemographic and health characteristics of the
patients such as age, gender, education level, marital status,
chronic disease, and comorbidity status. Information
regarding the current chronic diseases and comorbidities
were acquired by asking the patients directly. The questions
were formed as follows: “What is your current diagnosed
chronic disease?” and, “Do you have any other diagnosed
chronic disease other than the one you mentioned?”
2.2.1. The Self-Efficacy for Managing Chronic Disease
6-Item Scale
The Self-Efficacy for Managing Chronic Disease 6-Item
Scale was developed by Lorig and colleagues in English
in 2001 [15]. It is easy to use and an effective tool for
evaluating the self-efficacy level of patients with chronic
diseases. The scale is rated on a 10-point scale ranging
from “not at all confident” to “totally confident”. The score
for the scale is the mean of the 6 items, and high scores
indicate high self-efficacy. If more than 1 response is given
to an item and the items are consecutive, the lower score is
included in the calculation. If the 2 given responses are not
consecutive, this item is excluded from the calculation. In
order for the scale to be calculated, there must be at least
4 items answered1. There is a high internal consistency (α
= 0.91) and the mean of original scale is 5.17 ± 2.22 [15].
2.2.2. The General Perceived Self-Efficacy Scale
The General Perceived Self-Efficacy Scale was used for
examining the concurrent validity of the Self-Efficacy for
Managing Chronic Disease 6-Item Scale. The General
Perceived Self-Efficacy Scale, consisting of 10 items, is a
valid and reliable measurement tool in Turkish [23,24].
The scale measures the level of generalized perceived

Self-Management Resource Center. Self-Efficacy for Managing Chronic Disease 6-Item Scale. [online]. Website https://www.selfmanagementresource.
com/docs/pdfs/English_-_self-efficacy_for_managing_chronic_disease_6-item.pdf [accessed November 11, 2019].
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self-efficacy. Cronbach’s alpha of the scale was 0.89, and
Pearson’s product-moment correlation was between 0.64–
0.78, factor loading of the scale’s items changed from 0.64
to 0.79 in one factor structure, and test-retest correlation
was 0.83 [24]. In this study, Cronbach’s alpha was 0.94,
item-total score correlation was between 0.51–0.82, testretest correlation was 0.96 (P < 0.001) for the General
Perceived Self-Efficacy Scale.
2.3. Data collection
Data were collected via face-to-face interviews in the
counseling room in family health centers. The patients
were at first called by phone and the ones who accepted to
participate in the study were invited to the family health
center and interviews were initiated. Each interview lasted
15 min on average. Patients’ questions were also answered
during the interview. Four weeks after the first assessments,
the sampled patients were called again, and all assessments
were repeated for test-retest reliability. Because of selfefficacy is a changeable psychological condition, a shorter
(<2 weeks) retest period is recommended [11]. In the
recent validity and reliability studies of various self-efficacy
scales, this period was between 2–4 weeks [24–27,33]. In
this study, the retest period was set as 4 weeks.
2.4. Translation and cultural adaptation
The World Health Organization guideline suggests that
4 steps (forward translation, expert panel and backtranslation, pretesting and cognitive interviewing, final
version) are needed to achieve translation and adaptation
of different language versions of the English instrument2.
The English-to-Turkish translation of the scale was
independently done by the researchers. Two English
teachers working in the university and a professional
translator translated the scale from English to Turkish.
Then the scale was brought into a single form by the
researchers. Back-translation from Turkish to English was
independently done by 2 native English speakers living in
Turkey for many years. After the back-translation, the scale
items were revised in terms of grammar, clarity, cultural
properties, and it was made available for an expert panel.
The final Turkish translation was presented to a total of
12 healthcare experts working in various fields related to
chronic diseases (a diabetes specialist nurse, an internal
diseases specialist, and 10 nursing academicians with
expertise in chronic disease management) for a language
and content validity check. For content validity of the
scale, the experts evaluated each scale item with a 4-point
Likert-type scale (1 not relevant, 4 highly relevant). Items
given 1 and 2 points were rearranged by the researcher.
The Content Validity Index (CVI) score of the scale was
calculated by the proportion of items that were scored 3 or
4 points by the experts and if the score was 0.80 or higher,

it was considered acceptable [34,35]. In the direction of
expert evaluation, to shorten the questions and increase
clarity of the scale, the commonly used expression of
“How confident are you...” was subtracted from all of the
questions and added to the top of the scale. After the pilot
test of the scale was performed on 10 people with chronic
diseases, it was ready to be utilized for psychometric
assessments [Appendix 1].
2.5. Ethical considerations
After receiving institutional permission, the study was
approved by the Ethics Committee of Zeynep Kamil
Hospital (Ref. no. 045, date 05/04/2013). All patients were
informed, and written consents were obtained before data
collection.
2.6. Data analysis
Statistical analyses were carried out using SPSS 21.0
(IBM Corp., Armonk, NY, USA) and LISREL 8.80
(Lincolnwood, IL, USA) software. Descriptive data were
expressed via mean ± standard deviation (X ± SD),
minimums, maximums, and percentages (%). Validity
data were evaluated with concurrent validity, exploratory
(including Varimax rotation with Kaiser Normalization),
and confirmatory factor analysis. Data suitability for
factor analysis was analyzed using the Kaiser-Meyer-Olkin
(KMO) value and Bartlett’s test [30,36]. The items with
factor loadings 0.40 and above were included in the factor
structure [36]. The reliability of the scale was evaluated
with Cronbach’s alpha, item-total correlation, and testretest reliability. In evaluation of the results, the itemtotal score correlation was expected to be 0.30 or more,
and the retest correlation and alpha coefficient 0.70 or
more [36–38]. The comparisons between scale mean and
sample characteristics data were evaluated via regression
analysis. Concurrent validity and test-retest reliability
were evaluated via Pearson’s correlation analysis. The
significance level was considered as P < 0.05.
3. Results
3.1. Sample characteristics
Most of the participants with a mean age of 60.5 ± 10.9
(min 33, max 85) were women (72%), primary school
graduates (41.7%), hypertensive (68.7%), diabetic (15.6%),
asthmatic (7.1%), and had comorbidities (68.2%) (Table 1).
The average years of having one or more chronic disease
were 10.8 ± 9.8 (min 1, max 53). Mean score of the 6-Item
Scale and some characteristics of the participants (age,
sex, education, chronic diseases, and comorbidity) were
compared with regression analysis. It was showed that
the self-efficacy scores were lower in people with lower
educational status (β = 0.435, t = 6.892, P < 0.001) and

World Health Organization. Process of translation and adaptation of instruments. [online]. Website https://www.who.int/substance_abuse/research_
tools/translation/en/ [accessed November 11, 2019].
2

1256

İNCİRKUŞ and ÖZKAN NAHCİVAN / Turk J Med Sci
hypertension (β = –0.155, t = –2.478, P = 0.014). There was
no statistically significant difference between mean score
and age, sex, comorbidity, and other chronic diseases (P
˃ 0.05).
3.2. Validity
In this study, the validity of the scale was evaluated via
Content Validity Index (CVI), concurrent validity, factor
analysis and the CVI score of the scale was 0.81. For
concurrent validity, a positive, significant, and medium
correlation was found between the Self-Efficacy for
Managing Chronic Disease 6-Item Scale and the General
Perceived Self-Efficacy Scale (Pearson’s correlation, r =
0.54, P < 0.001).
Before factor analysis, Kaiser-Meyer-Olkin (KMO)
value and Bartlett’s test results were assessed. KMO value

was 0.794 and Bartlett’s test was found significant (χ2
= 1136.546, P < 0.001). The results of exploratory factor
analysis were showed that the scale had 2-factor structure,
and 98.02% of total variance was explained by 2 factors.
Factor 1 explained 94.50% and factor 2 explained 3.52% of
total variance. Factor loadings of the scale were between
0.83–0.95 for exploratory factor analysis and between
0.77–0.98 for confirmatory factor analysis. Eigenvalues,
% of variance, factor loadings for exploratory (EFA)
and confirmatory (CFA) factor analysis, and Cronbach’s
Alpha values for each factor are shown in Table 2. Chisquare value was significant (χ2 = 21.52, df = 8, P = 0.006,
RMSEA = 0.090). The other fit index values of the scale
were; IFI (incremental fit index) = 0.99, GFI (goodness of
fit index) = 0.97, NNFI (nonnormed fit index) = 0.98, CFI

Table 1. General characteristics of the participants (N = 211).
Characteristics
Gender

Education level

Marital status

Chronic diseases

Comorbidity

n

(%)

Female

152

(72.0)

Male

59

(28.0)

Literate

23

(10.9)

Primary School

88

(41.7)

Secondary School

19

(9.0)

High School

44

(20.9)

University

37

(17.5)

Married

149

(70.6)

Single

62

(29.4)

Hypertension

145

(68.7)

Diabetes

33

(15.6)

Asthma

15

(7.1)

Other (COPD, depression etc.)

18

(8.6)

Yes

144

(68.2)

No

67

(31.8)

Table 2. Eigenvalues, % of variance, factor loadings for exploratory (EFA), and confirmatory (CFA) factor analysis and Cronbach’s
alpha values for each factor.
Factor loadings for EFA

Factor loadings for CFA

Factor 1

Factor 2

Factor 1

Factor 2

66.529

0.83

0.21

0.77

-

19.732

0.88

0.19

0.85

-

0.357

5.949

0.89

0.21

0.88

-

4

0.256

4.268

0.86

0.35

0.94

-

5

0.145

2.423

0.24

0.95

-

0.95

6

0.066

1.100

0.26

0.95

-

0.98

Scale Items

Eigenvalues

% of Variance

1

3.992

2

1.184

3

Cronbach’s
alpha values

0.92

0.96
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(comparative fit index) = 0.99, SRMR (standardized rootmean square residual) = 0.027. Standardized confirmatory
factor analysis path diagram is presented in Figure.
3.3. Reliability
The item-total correlations, the Cronbach’s alpha
coefficient, and test-retest correlations were evaluated in
this study. Item-total correlations were ranged from 0.64
to 0.85 (P < 0.001) and the scale mean was 5.66 ± 2.28
(Table 3). Cronbach’s alpha reliability of the scale was 0.90.

In order to examine the stability in terms of time, the testretest reliability was implemented with 116 patients who
filled in the scale before. During the course of 1 month
(4 weeks) the test-retest reliability was high (Pearson’s
correlation, r = 0.95, P < 0.001).
4. Discussion
Being an important outcome variable, self-efficacy is a
part of the long-term behavioral change process and is a

Figure. Standardized confirmatory factor analysis (CFA) path diagram for Turkish version
of the Self-Efficacy for Managing Chronic Disease 6-Item Scale.
Table 3. Mean, standard deviation (SD), minimum-maximum (Min-Max), and item-total correlations of the scale items (N = 211).
Min-max

Item-total
correlations

1. How confident are you that you can keep the fatigue caused by your disease from 5.39
interfering with the things you want to do?
(± 2.27)

2–10

0.70

2. How confident are you that you can keep the physical discomfort or pain of your 5.57
disease from interfering with the things you want to do?
(± 2.74)

2–10

0.75

3. How confident are you that you can keep the emotional distress caused by your
disease from interfering with the things you want to do?

5.20
(± 2.99)

2–10

0.76

4. How confident are you that you can keep any other symptoms or health problems 5.39
you have from interfering with the things you want to do?
(± 2.74)

2–10

0.85

5. How confident are you that you can do the different tasks and activities needed to 6.25
manage your health condition so as to reduce you need to see a doctor?
(± 2.76)

2–10

0.64

6. How confident are you that you can do things other than just taking medication
to reduce how much your illness affects your everyday life?

6.14
(± 2.79)

2–10

0.65

Total scale item mean (± SD), min-max

5.66 (± 2.28), 2–10

Scale Items
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prerequisite for successful chronic disease management
[10–12]. Self-efficacy assessment is an increasingly
critical concept in planning and evaluating the selfmanagement programs in chronic diseases, determining
individual differences among patients, and estimating
important health outcomes [11]. Especially on scales
that assess the abstract concepts such as self-efficacy,
validity, and reliability value is becoming more important
in the adaptations of the scales developed in different
languages and cultures. Validity shows how accurately
a tool measures something [34,36]. Validity data were
evaluated with content validity index, exploratory and
confirmatory factor analysis, and concurrent validity. The
language equivalence of the translated version of the scale
from English to Turkish was evaluated with the Content
Validity Index. The CVI score is expected to be above 0.80
[31,34–36], so it was adequate (0.81) in this study.
The scale showed a 2-dimensional structure in both
factor analyses. Although the result of factor analysis
has not been given in the original study [15], the scale
has been found to have 1-dimensional structure in other
studies except the Chinese study [16,39,40]. In our study,
similar to the Chinese study [16], items 5 and 6 have
been gathered under the factor 2. Hu and colleagues [16]
reported 2 possible reasons for this situation. First, while
the first 4 items were stressing the psychological attitude,
the last 2 items were stressing behavioral attitude. Hu and
colleagues stated as the second reason that the results
could be specific to the sample of their research. In the
sample of their study, it is pointed out that the lack of age
and literacy alternatives, the high number of women, and
participants who might tend to give the desired results in
face-to-face interviews may have affected the study results
[16]. In this study, the majority of the sample was female
and the use of face-to-face interviews to collect data may
have led to similar results.
Concurrent validity evaluates an instrument’s validity
by comparing it to a valid scale or test [36]. In the German
study [39], the same scale was used for concurrent
validity and a good correlation was found (r = 0.578, P <
0.001). Concurrent validity was evaluated with Hospital
Anxiety and Depression Scale in the Chinese study [16]
and with Health Education Impact Questionnaire in the
French study [33]. It was reported that the 6-item scale
showed a significant correlation with Hospital Anxiety
and Depression Scale (r = – 0.30, P < 0.001) and Health
Education Impact Questionnaire (r = 0.49, P < 0.001)
[16,33]. For concurrent validity, a positive and significant
correlation was found in this study (r = 0.54, P < 0.001).
The results obtained in this study were similar to the results
of studies carried out in other languages. A significant and
good correlation was found between the Self-Efficacy for
Managing Chronic Disease 6-Item Scale and the General

Perceived Self-Efficacy Scale.
The reliability of the scale was evaluated with the
Cronbach’s alpha coefficient, item-total statistics, testretest correlations in this study. Publications related to
research methodologies indicate that test-retest reliability
and Cronbach’s alpha values should be higher than 0.70
[36–38]. Cronbach’s alpha reliability was between 0.88–
0.93 in the validity and reliability studies of the scale in the
other languages [15,16,33,39,40]. Alpha coefficient of the
study was found to be high (α = 0.90) in our study, and this
value was similar to the results of the other validity and
reliability studies. Although the test-retest period (4 weeks)
took longer than other validity and reliability studies of
self-efficacy scales [24–27,33], test-retest reliability was
found to be very high (r = 0.95, P < 0.001) in this study
(n = 116). The test-retest reliability was 0.78 [16] and 0.82
[33] in other validity and reliability studies of the 6-item
scale. Item-total correlations were between 0.64–0.85 (P <
0.001) and this value was considered good compared to
the suggested value (>0.30) [36,38]. It was also similar to
the results of other studies [16,33,39,40].
Although this study focused on examining the
psychometric properties of the Self-Efficacy for Managing
Chronic Disease 6-Item Scale, the mean self-efficacy
score was compared to the sociodemographic and health
characteristics of the total sample. It was showed that selfefficacy scores were lower in people who were hypertensive
and with lower educational status; however, no correlation
was found between age, sex, number of comorbidities,
other chronic diseases, and scale scores in this study.
Similar to these results, in the study of Dongbo et al. [41]
it was reported that higher education is associated with
higher self-efficacy and better health outcomes. In another
study in which sociodemographic data and scale scores
were compared, a negative correlation was found between
age, sex, number of comorbidities, and the self-efficacy
scores, but no correlation was found between educational
status and the self-efficacy scores [39].
Although significant and positive results were
obtained, the patients constituting the sample of the study
were selected from only 2-family health centers and most
of these patients had hypertension and diabetes. Although
this situation reduced the strength of the sample that
represents patients with different chronic health problems,
these diseases were stated within the first 3 diseases in
the original study as well as other validity and reliability
studies.
In conclusion, the Turkish version of the Self-Efficacy
for Managing Chronic Disease 6-Item Scale is a reliable
and validated instrument to assess the self-efficacy level
perceived by patients with chronic disease. Self-efficacy is
a prerequisite and predictor of successful chronic disease
self-management [10,39]. By using the 6-item Scale in
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the assessment of individuals who need to improve their
self-efficacy, the development of effective practices that
increase the level of self-efficacy and improvement of
chronic disease self-management will be provided [16,40].
It is also stated that the scale can be used to assess patient
participation as well as the difference according to initial
assessment of self-efficacy [40]. The results of our study
showed good external validity, high internal consistency
and test-retest reliability, and 2-dimensional structure.
Further studies are recommended in a larger sample group
representing individuals with chronic diseases who use the

scale of health professionals in the management of chronic
diseases.
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Appendix 1. Turkish version of the Self-Efficacy for Managing Chronic Disease 6-Item Scale [Kronik Hastalık Yönetimi İçin 6 Maddelik
Öz-Etkililik Ölçeği].
Kronik hastalığı olan bireyler için öz-yönetim günlük hayatın bir parçasıdır. Aşağıda kronik hastalığınızın yönetiminde
karşılaşabileceğiniz bazı faaliyetler verilmiştir. Size daha iyi bir sağlık hizmeti sunabilmemiz için, bu faaliyetleri yapma konusunda ne
kadar emin olduğunuzu öğrenmek istiyoruz. Lütfen aşağıda yer alan her bir ifadeyi dikkatlice okuyarak yanıt vermeye çalışınız. Şu anda
düzenli olarak yapabileceğiniz durumlar için kendinize olan güveninize karşılık gelen uygun sayıyı seçiniz ve seçtiğiniz sayıyı yuvarlak
içine alınız. Lütfen her bir ifadenin cevaplanmış olmasına dikkat ediniz.
Hastalığınızın neden olduğu sorunları yönetmede kendinize ne kadar güveniyorsunuz?
1. Yorgunluğumun yapmak istediklerimi etkilemesini
önleyebilirim.
2. Fiziksel rahatsızlık ve ağrımın yapmak istediklerimi
etkilemesini önleyebilirim.
3. Duygusal sıkıntımın yapmak istediklerimi etkilemesini
önleyebilirim.
4. Sağlık problemleri ve diğer belirtilerimin yapmak istediklerimi
etkilemesini önleyebilirim.
5. Doktora daha az gitmek için, sağlığım ile ilgili çeşitli görev ve
aktiviteleri yapabilirim.
6. Hastalığımın günlük yaşamıma olan etkilerini azaltmak için,
ilaç almaktan başka şeyler de yapabilirim.
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